Lilla Lénárt

481 total citations
21 papers, 370 citations indexed

About

Lilla Lénárt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lilla Lénárt has authored 21 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lilla Lénárt's work include Neuropeptides and Animal Physiology (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Receptor Mechanisms and Signaling (4 papers). Lilla Lénárt is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Receptor Mechanisms and Signaling (4 papers). Lilla Lénárt collaborates with scholars based in Hungary, Denmark and United States. Lilla Lénárt's co-authors include Andrea Fekete, Judit Hodrea, Attila J. Szabó, Dóra Balogh, Ádám Hosszú, László Wagner, Ádám Vannay, Federica Genovese, János Nemcsik and Nóra Fanni Bánki and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Diabetes.

In The Last Decade

Lilla Lénárt

19 papers receiving 362 citations

Peers

Lilla Lénárt
Yejun Zhao United States
Soo-Hyun Park South Korea
Fiona Hanner United States
Pablo Martínez United States
Karen Sooy United Kingdom
Yejun Zhao United States
Lilla Lénárt
Citations per year, relative to Lilla Lénárt Lilla Lénárt (= 1×) peers Yejun Zhao

Countries citing papers authored by Lilla Lénárt

Since Specialization
Citations

This map shows the geographic impact of Lilla Lénárt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilla Lénárt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilla Lénárt more than expected).

Fields of papers citing papers by Lilla Lénárt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilla Lénárt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilla Lénárt. The network helps show where Lilla Lénárt may publish in the future.

Co-authorship network of co-authors of Lilla Lénárt

This figure shows the co-authorship network connecting the top 25 collaborators of Lilla Lénárt. A scholar is included among the top collaborators of Lilla Lénárt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilla Lénárt. Lilla Lénárt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ecsedy, Mónika, et al.. (2024). Association of SDF-1-3′ Gene A Variant with Diabetic Retinopathy in the Hungarian Population. International Journal of Molecular Sciences. 25(15). 8036–8036.
2.
Balogh, Dóra, Lilla Lénárt, Ádám Hosszú, et al.. (2023). 10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease. Diabetes. 72(Supplement_1). 1 indexed citations
3.
Balogh, Dóra, Judit Hodrea, Ádám Hosszú, et al.. (2021). MO620ANTIFIBROTIC EFFECTS OF SGLT2 INHIBITION IN THE KIDNEY AND PROXIMAL TUBULAR CELLS*. Nephrology Dialysis Transplantation. 36(Supplement_1). 1 indexed citations
4.
Hodrea, Judit, Dóra Balogh, Ádám Hosszú, et al.. (2020). Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney. American Journal of Physiology-Renal Physiology. 318(4). F1017–F1029. 40 indexed citations
5.
Lénárt, Lilla, Ádám Hosszú, Illés Kovács, et al.. (2020). P1669PROGNOSTIC IMPORTANCE OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) IN RENAL TRANSPLANTATION. Nephrology Dialysis Transplantation. 35(Supplement_3). 2 indexed citations
6.
Hosszú, Ádám, Dóra Balogh, Lilla Lénárt, et al.. (2020). Sigma‐1 Receptor Agonists Are Renoprotective in Experimental Kidney Transplantation. The FASEB Journal. 34(S1). 1–1.
7.
Balogh, Dóra, Ádám Hosszú, Judit Hodrea, et al.. (2020). Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition. Psychoneuroendocrinology. 118. 104705–104705. 15 indexed citations
8.
Lénárt, Lilla, Dóra Balogh, Nikolett Lénárt, et al.. (2019). Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling. Diabetologia. 62(8). 1501–1513. 19 indexed citations
9.
Lénárt, Lilla, et al.. (2019). The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections. Journal of Neural Transmission. 126(3). 265–278. 21 indexed citations
10.
Lénárt, Lilla, Judit Hodrea, Dóra Balogh, et al.. (2018). RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition. The Journal of Physiology. 597(1). 193–209. 73 indexed citations
11.
Hosszú, Ádám, Zsuzsanna Antal, Lilla Lénárt, et al.. (2018). The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury. Transplant International. 31(11). 1268–1278. 17 indexed citations
12.
Lénárt, Lilla, Judit Hodrea, Dóra Balogh, et al.. (2018). FP429THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS AMELIORATE HYPERGLYCAEMIA INDUCED TUBULOINTERSITIAL FIBROSIS IN DIABETIC NEPHROPATHY. Nephrology Dialysis Transplantation. 33(suppl_1). i179–i179. 5 indexed citations
13.
Tabák, Ádám G., Lilla Lénárt, Andrea Fekete, et al.. (2017). The impact of currently recommended antihypertensive therapy on depression and other psychometric parameters: preliminary communication.. PubMed. 19(1). 11–22. 11 indexed citations
14.
Lénárt, Lilla, Judit Hodrea, Ádám Hosszú, et al.. (2016). The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats. Psychopharmacology. 233(7). 1269–1278. 21 indexed citations
15.
Ecsedy, Mónika, et al.. (2016). Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion. PLoS ONE. 11(11). e0166544–e0166544. 5 indexed citations
16.
Nemcsik, János, Lilla Lénárt, Péter Torzsa, et al.. (2016). Hyperthymic affective temperament and hypertension are independent determinants of serum brain-derived neurotrophic factor level. Annals of General Psychiatry. 15(1). 17–17. 22 indexed citations
17.
Hodrea, Judit, Lilla Lénárt, Ádám Hosszú, et al.. (2016). Role ofO-linkedN-acetylglucosamine modification in diabetic nephropathy. American Journal of Physiology-Renal Physiology. 311(6). F1172–F1181. 38 indexed citations
18.
Hosszú, Ádám, Zsuzsanna Antal, Lilla Lénárt, et al.. (2016). σ1-Receptor Agonism Protects against Renal Ischemia-Reperfusion Injury. Journal of the American Society of Nephrology. 28(1). 152–165. 45 indexed citations
19.
Eőry, Ajándék, László Kalabay, Xénia Gonda, et al.. (2015). Identification of hypertensive patients with dominant affective temperaments might improve the psychopathological and cardiovascular risk stratification: a pilot, case–control study. Annals of General Psychiatry. 14(1). 33–33. 12 indexed citations
20.
Bánki, Nóra Fanni, Ágota Vér, László Wagner, et al.. (2012). Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats. PLoS ONE. 7(6). e39938–e39938. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026